| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0001 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.16 | 0.0006 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |